Safety and efficacy of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis: 9 years' follow-up of DEFINE, CONFIRM, and ENDORSE.
Ralf GoldDouglas L ArnoldAmit Bar-OrRobert J FoxLudwig KapposChongshu ChenBecky ParksCatherine MillerPublished in: Therapeutic advances in neurological disorders (2020)
ClinicalTrials.gov identifiers, NCT00835770 (ENDORSE); NCT00420212 (DEFINE); NCT00451451 (CONFIRM).